Draegerwerk AG KGaAHAM:DRW8 75 EBITDA Margin % is 2.76% as of Mar. 2026, which is 52% below its 10-year median of 5.79. GuruFocus rates HAM:DRW8 with a GF Score™ of 75/100 and a GF Value™ of €47.04 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Draegerwerk AG KGaA ranks worse than 50.12% on this metric.
Draegerwerk AG KGaA (HAM:DRW8) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Draegerwerk AG KGaA EBITDA Margin % Related Terms
Draegerwerk AG KGaA EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Draegerwerk AG KGaA's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HAM:DRW8 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Draegerwerk AG KGaA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Draegerwerk AG KGaA EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Draegerwerk AG KGaA's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Draegerwerk AG KGaA's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Draegerwerk AG KGaA (HAM:DRW8) has a EBITDA Margin % of 2.76% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Draegerwerk AG KGaA and its competitors. This is 52% below median its historical median of 5.79. According to the industry distribution chart, Draegerwerk AG KGaA ranks #409 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Draegerwerk AG KGaA's EBITDA Margin % too high?
Draegerwerk AG KGaA's current EBITDA Margin % of 2.76% is 52% below median its 10-year median of 5.79. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Draegerwerk AG KGaA's value of 2.76% is 63.1% below this industry median. Based on the distribution chart, Draegerwerk AG KGaA ranks #409 out of 816 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Draegerwerk AG KGaA has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Draegerwerk AG KGaA's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Draegerwerk AG KGaA ranks #409 out of 816 companies for EBITDA Margin %. This places Draegerwerk AG KGaA in the lower half of its industry. The industry median EBITDA Margin % is 7.48. Draegerwerk AG KGaA's value of 2.76% is 63.1% below this benchmark. While the company's 10-year median is 5.79 vs. the industry median of 7.48, Draegerwerk AG KGaA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Draegerwerk AG KGaA's current EBITDA Margin % of 2.76% is 63.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Draegerwerk AG KGaA and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Draegerwerk AG KGaA's current EBITDA Margin % is 2.76%, which is 52% below median its own 10-year median of 5.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Draegerwerk AG KGaA stock overvalued right now?
Based on GuruFocus' analysis, Draegerwerk AG KGaA (HAM:DRW8) is currently considered Significantly Overvalued. The stock's GF Value™ is €47.04, compared to a current price of €70.20 — trading 49.2% above its estimated fair value. The current EBITDA Margin % is 2.76%, which is 52% below median its 10-year median of 5.79 and 63.1% below the Medical Devices & Instruments industry median of 7.48. Draegerwerk AG KGaA's overall GF Score™ is 75/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Draegerwerk AG KGaA (HAM:DRW8), the current EBITDA Margin % is 2.76% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Draegerwerk AG KGaA (HAM:DRW8) Overvalued in 2026?
Based on GuruFocus' analysis, Draegerwerk AG KGaA stock appears to be overvalued.
The current stock price of €70.20 is trading 49.2% above its estimated GF Value™ of €47.04.
GuruFocus considers Draegerwerk AG KGaA to be Significantly Overvalued.
Key valuation signals for HAM:DRW8:
EBITDA Margin %: 2.76% (52% below median its 10-year median of 5.79)
GF Value™: €47.04 vs. price of €70.20 (49.2% above fair value)
Industry Position: 63.1% below the Medical Devices & Instruments median (#409 of 816)
No single metric tells the full story. See the HAM:DRW8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Draegerwerk AG & Co KGaA develops medical and safety equipment for clinical and industrial applications. The firm operates in two segments: medical and safety. The medical division contributes the majority of revenue, it develops and produces system solutions, equipment, and services for the acute point of care, it has five business units Therapy, Hospital Consumables & Accessories, Workplace Infrastructure, Monitoring, and Data Business. Its safety division develops and produces devices, system solutions, and services for personal protection, gas detection, and integrated hazard management. Its geographical segments are Europe; Germany; the Americas; Africa, Asia, and Australia.
75GF Score
Get the complete analysis for HAM:DRW8
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:DRW8 has been successfully added to your 
